The Evaluation of a Preparatory Information Movie on Oocyte Aspiration
POAM-RCT
1 other identifier
interventional
155
1 country
1
Brief Summary
The Preparatory information on Oocyte Aspiration Movie Randomized Controlled Trial (POAM-RCT) primarily aims to evaluate whether a new preparatory information on oocyte aspiration movie (POAM) decreases the anxiety of women on the day of their first oocyte aspiration for in vitro fertilisation (IVF). The control group of this RCT will receive care as usual. The intervention group will additional be given access to a preparatory information movie on oocyte aspiration 1-3 days before their oocyte aspiration via a secured link. Women's anxiety will be assessed with the 'State module of the State Trait Anxiety Inventory (STAI-state)' upon arrival at the fertility clinic on the day of the oocyte aspiration. At the same time other questionnaires will be administered. More specifically, men's anxiety and both partner's infertility specific distress will be assessed. In addition, to these secondary outcomes, clinical pregnancy with fetal heart beat and miscarriage will be followed-up 12 weeks after the oocyte aspiration. Finally, treatment delay and treatment discontinuation and long-term clinical outcomes (i.e. live birth from the first fresh embryo transfer, clinical pregnancy with fetal heart beat from the frozen embryo transfers of 1st IVF-cycle and the 12-months cumulative clinical pregnancy rates) will be followed-up twelve months after oocyte aspiration. This RCT will include 190 women (and their male partners) treated with a 1st cycle of IVF (with or without ICSI and PGD). Analysis will be according to intention to treat.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2018
CompletedFirst Posted
Study publicly available on registry
October 24, 2018
CompletedStudy Start
First participant enrolled
October 29, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 24, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 24, 2022
CompletedAugust 20, 2024
July 1, 2024
1.9 years
October 10, 2018
August 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Women's state anxiety
Women's anxiety will be assessed with the 'State Trait Anxiety Inventory, state module (STAI-state; score 20-80, the higher the more anxious)' questionnaire (Spielberger et al, 2015; www.mingarden.com).
Responses on one single assessment of state-anxiety on the day of the oocyte aspiration (1-3 days after the intervention or control condition) will be compared between intervention and control group. No pre-intervention assessment, no change scores.
Secondary Outcomes (10)
Men's state anxiety
Responses on one single assessment of state-anxiety on the day of the oocyte aspiration (1-3 days after the intervention or control condition) will be compared between intervention and control group. No pre-intervention assessment, no change scores.
Women's infertility specific distress
Responses on one single assessment of distress on the day of the oocyte aspiration (1-3 days after the intervention or control condition) will be compared between intervention and control group. No pre-intervention assessment, no change scores.
Men's infertility specific stress
Responses on one single assessment of distress on the day of the oocyte aspiration (1-3 days after the intervention or control condition) will be compared between intervention and control group. No pre-intervention assessment, no change scores.
Clinical pregnancy with fetal heart beat
A medium duration after intervention or control condition: 12 weeks after oocyte aspiration
Miscarriage after clinical pregnancy with fetal heart beat
A medium duration after intervention or control condition: 12 weeks after oocyte aspiration
- +5 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALParticipating couples of the intervention group will receive care as usual and will watch the preparatory information movie on oocyte aspiration (POAM) 1-3 days before their oocyte aspiration. Their gynecologist or midwife will empower them to watch the movie when they call them to plan the oocyte aspiration and will send them the secured link to the movie via email.
Control group
NO INTERVENTIONParticipating couples of the control group will receive care as usual (as will participating couples of the intervention group) and will not get access to the preparatory information movie on oocyte aspiration (POAM).
Interventions
The new 5 minutes preparatory information movie on oocyte aspiration (POAM) details what couples can expect to happen on the day of oocyte aspiration. More specifically, it describes the patient journey detailing which procedures will happen when and how, in which room, in the presence of their partner or not, and in the presence of which healthcare professionals.
Eligibility Criteria
You may qualify if:
- (i) Heterosexual woman and her partner
- (ii) Dutch speaking
- (iii) Treated with a 1st cycle of IVF (IVF or ICSI; with or without PGD)
You may not qualify if:
- (i) Having already experienced an IVF-cycle in the same of another clinic
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
GZA Ziekenhuizen campus Sint-Augustinus
Wilrijk, Antwerpen, 2610, Belgium
Related Publications (1)
Dias L, De Loecker P, Willems S, D'Hooghe TM, Vriens J, Peeraer K, Dancet EAF. A video clip detailing the patient journey on the day of oocyte retrieval in addition to the standard of care: a randomized controlled trial. Hum Reprod. 2025 Apr 1;40(4):664-674. doi: 10.1093/humrep/deaf033.
PMID: 40056004DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karen Peeraer, PhD
Universitaire Ziekenhuizen KU Leuven
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2018
First Posted
October 24, 2018
Study Start
October 29, 2018
Primary Completion
September 24, 2020
Study Completion
September 24, 2022
Last Updated
August 20, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share